Mendiratta-Lala, Mishal http://orcid.org/0000-0003-4055-916X
Aslam, Anum
Bai, Harrison X.
Chapiro, Julius
De Baere, Thiery
Miyayama, Shiro
Chernyak, Victoria
Matsui, Osamu
Vilgrain, Valerie
Fidelman, Nicholas
Article History
Received: 24 May 2023
Revised: 10 August 2023
Accepted: 20 August 2023
First Online: 6 November 2023
Declarations
:
: The scientific guarantor of this publication is Mishal Mendiratta-Lala MD.
: The authors of this manuscript declare relationships with the following companies:Julius Chapiro—Consultant/Grants: AstraZeneca, Bayer, Guerbet, Boston Scientific.Thiery de Baere—speaker honorarium from Guerbet, Terumo, GE Healthcare, AstraZeneca, a research grant from Terumo, and GE Healthcare.Shiro Miyayama—lecture fees from Guerbet, Asahi Intecc, and Philips Healthcare.Victoria Chernyak—Bayer – consultant.Nicholas Fidelman—Research grants from Merck, Boston Scientific, and Sirtex Medical.
: No complex statistical methods were necessary for this paper.
: Review manuscript, no informed consent was required.
: Institutional Review Board approval was not required because this is a review paper.
: No.
: • review